In our study, we found that in tumor tissue from the BRAF mutant group, TNFRSF1B (encoding TNFR2) was significantly hypomethylated, suggesting potential overexpression of TNFR2 in this group of patients. This evidence concerns the gene TNFRSF1B and neoplasm.